Renal Outcome of IgM Nephropathy: A Comparative Prospective Cohort Study
Authors:
- Yura ChaeYCYura Chae
- Hye Eun YoonHYHye Eun Yoon
- Yoon Kyung ChangYCYoon Kyung Chang
- Young Soo KimYKYoung Soo Kim
- Hyung Wook KimHKHyung Wook Kim
- Bum Soon ChoiBCBum Soon Choi
- Cheol Whee ParkCPCheol Whee Park
- Ho Cheol SongHSHo Cheol Song
- Young Ok KimYKYoung Ok Kim
- Eun Sil KohEKEun Sil Koh
- Sungjin ChungSCSungjin Chung
Open Access
- 16 September 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (18) , 4191
Abstract
Immunoglobulin M nephropathy (IgMN) is an idiopathic glomerulonephritis characterized by diffuse deposits of IgM in the glomerular mesangium. However, its renal prognosis remains unknown. We compared renal outcomes of IgMN patients with those of patients with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), or mesangial proliferative glomerulonephritis (MsPGN) from a prospective observational cohort, with 1791 patients undergoing native kidney biopsy in eight hospitals affiliated with The Catholic University of Korea between December 2014 and October 2020. IgMN had more mesangial proliferation and matrix expansion than MsPGN and more tubular atrophy and interstitial fibrosis than MCD. IgMN patients had decreased eGFR than MCD patients in the earlier follow-up. However, there was no significant difference in urine protein or eGFR among all patients at the last follow-up. When IgMN was divided into three subtypes, patients with FSGS-like IgMN tended to have lower eGFR than those with MCD-like or MsPGN-like IgMN but higher proteinuria than MsPGN-like IgMN without showing a significant difference. The presence of hypertension at the time of kidney biopsy predicted ≥20% decline of eGFR over two years in IgMN patients. Our data indicate that IgMN would have a clinical course and renal prognosis similar to MCD, FSGS, and MsPGN.Keywords
This publication has 32 references indexed in Scilit:
- IgM nephropathy revisitedNephro-Urology Monthly, 2012
- The prevalence and clinicopathological profile of IgM nephropathy in children with steroid-resistant nephrotic syndrome at a single centre in PakistanJournal of Clinical Pathology, 2012
- IgA Nephropathy: Progress Before and Since BergerAmerican Journal of Kidney Diseases, 2011
- Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk PredictionsAmerican Journal of Kidney Diseases, 2010
- Resolution of IgM Nephropathy After Rituximab TreatmentAmerican Journal of Kidney Diseases, 2009
- IgM nephropathy: Clinical picture and long-term prognosisAmerican Journal of Kidney Diseases, 2003
- Clinical manifestations and progression of IgM mesangial nephropathy: a single center prospectiveHong Kong Journal of Nephrology, 2000
- Distinguishing minimal-change disease from mesangial disordersKidney International, 1988
- Morphological Transition in Minimal Change Nephrotic SyndromeNephron, 1985
- No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndromeKidney International, 1984